Patents Assigned to MEDICARE LC.
  • Publication number: 20220119381
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 21, 2022
    Applicants: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun NA, Kyung Pyo KANG, Jin Hwan JUN, Geon GO, Hyeon Jun NA, Sang Jin KANG, Young Hyun NA, Se Jin YOON, Su Ji NA
  • Patent number: 11292789
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 5, 2022
    Assignees: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun Na, Kyung Pyo Kang, Jin Hwan Jun, Geon Go, Hyeon Jun Na, Sang Jin Kang, Young Hyun Na, Se Jin Yoon, Su Ji Na